Dune: Part Two, the anticipated follow-up to 2021’s six-time Oscar-winning Dune, was written by Denis Villeneuve and Jon ...

After about five years working behind the scenes, Arrakis Therapeutics is unveiling that its lead program will aim to treat ...

The world of Arrakis is yours for the taking, if you can do it with the right resources and pieces of land in the game Risk: ...

The co-writers came together to talk about adapting Frank Herbert’s beloved sci-fi novel at THR’s Frontrunner awards ...

"Dune"-inspired Arrakis Therapeutics has tested its spice—an RNA-targeting small molecule—in a mouse model of myotonic ...

ArrakisTx was formed to create RNA-intercepting drugs to fight cancer. Despite some promising data, CEO @michael_gilman says it will shift targets.

Before Denis Villeneuve, before David Lynch, Alien and Blade Runner director Ridley Scott almost made a very different ...

Dune: Prophecy is slowly revealing its true villain as each episode passes and, in Episode 4, we finally get a look at its ...

Gilead CEO Daniel O’Day has hired Berger away from Sanofi. Elsewhere, Lonza is reorganizing and Bausch + Lomb is exploring a ...

Denis Villeneuve responds to Josh Brolin saying he will quit acting if the Dune director doesn't get nominated for an Academy ...